|
Glycemic disorders in melanoma patients treated with anti-PD1. |
|
|
|
Travel, Accommodations, Expenses - Novartis |
|
|
Honoraria - Bristol-Myers Squibb; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; MSD; Sanofi |
Research Funding - ION Pharma; Sanofi |
Expert Testimony - Aegerion; Amgen; Sanofi |
Travel, Accommodations, Expenses - Amgen; Lilly; MSD; Novo Nordisk; Sanofi |
|
|
No Relationships to Disclose |